ITI Life Sciences said yesterday it will provide another £2m to extend a research programme designed to develop technologies for use in the pharmaceutical industry to predict the effects of drug compounds in the human body.
- Text size
ITI Life Sciences and CXR move on funds packages
ITI Life Sciences said yesterday it will provide another £2m to extend a research programme designed to develop technologies for use in the pharmaceutical industry to predict the effects of drug compounds in the human body.
